Foundation Medicine, Eisai, pursue Dx for cancer drug; Beware Chinese device market pitfalls

 @FierceMedDev: AngioDynamics has agreed to purchase Vortex Medical for $55M. News | Follow @FierceMedDev

 @MarkHFierce: Stem cells derived from skin to be tested in humans as eye disease treatment--via Bloomberg. Article | Follow @MarkHFierce

 @DamianFierce: Boston Scientific will pay up to $265M for Rhythmia Medical. News | Follow @DamianFierce

> Foundation Medicine is teaming up with Eisai to handle genomic profiling and diagnostic discovery in a worldwide clinical trial of a cancer treatment. News

> SkelRegen, a startup helmed by a former Medtronic ($MDT) president and the director of Emory University Orthopaedics and Spine Center, is developing molecular compounds to regenerate bone tissue. Article

> The growing Chinese medical device market may seem alluring, but there are many pitfalls that face devicemakers looking to expand into the country, according to a report from Millennium Research Group. More

> The FDA has posted a warning letter citing Hospira ($HSP) for infusion pump manufacturing violations at its Costa Rica facility. Letter

> Navidea Biopharmaceuticals ($NAVB) is touting more positive clinical results for Lymphoseek, its diagnostic aid that has face delays on the path to FDA approval. Item

> Hygieia snagged a CE mark for its d-Nav Diabetes Insulin Guidance System, designed to update insulin dosage as needed. More

> Masimo ($MASI) got 510(k) clearance for its uSpO2 universal pulse oximetry cable, designed for use with GE Healthcare's ($GE) ApexPro Telemetry Systems. Release

> Boston Scientific ($BSX) has launched the Victory guidewire, designed to facilitate the placement of catheters and other devices in the peripheral arteries. Story

Biotech News

 @FierceBiotech: Fight against 'unwarranted' drug patents goes online. FierceBiotechIT article | Follow @FierceBiotech

 @JohnCFierce: Interesting. Twitter conclusion: Solanezumab a complete bust. But on BMBG, Reuters etc., it's an intriguing "win" for patients. Disconnect. | Follow @JohnCFierce

 @RyanMFierce: Magic Johnson is using his celebrity to bring attention to OraSure's at-home HIV test. A good use of his celebrity, I think.  | Follow @RyanMFierce

> Merck to shutter longtime NJ HQ in corporate reshuffle. News

> Billionaire Kirk orchestrates $45M cell therapy tie-up in biotech deal spree. Story

> Merck taps startup from Down Under for vaccine patch. Article

> Eli Lilly surges on conflicting data for Alzheimer's drug solanezumab. Report

Pharma News

@FiercePharma: Scotland rejects Avastin for ovarian cancer. Roche says the Scots need a cancer-drugs fund like England's. Report | Follow @FiercePharma

> Roche: Scotland needs funding for rejected cancer meds. Article

> Merck plots HQ move to former Schering site. More

> J&J eyes new Doxil process to reverse shortage. Story

Pharma Manufacturing News

> Compounder tied to meningitis deaths sold large quantities. News

> Sanofi Pasteur reports more issues with vaccine quality. Story

> Mold found in Hospira dextrose solution. Report

Biotech Research News

> Japanese scientists weld stem cells to create eggs and then baby mice. More

> RXi gains SBIR grant to pursue RNAi eye cancer drug. News

> Athersys stem cell therapy displays power as MS treatment. Article

> Inovio preclinical results prove skin delivery potency for DNA vaccines. Story

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.